Page last updated: 2024-11-02

pd 98059 and Colitis, Granulomatous

pd 98059 has been researched along with Colitis, Granulomatous in 2 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sugihara, T1
Kobori, A1
Imaeda, H1
Tsujikawa, T1
Amagase, K1
Takeuchi, K1
Fujiyama, Y1
Andoh, A1
Xin, X1
Hou, YT1
Li, L1
Schmiedlin-Ren, P1
Christman, GM1
Cheng, HL1
Bitar, KN1
Zimmermann, EM1

Other Studies

2 other studies available for pd 98059 and Colitis, Granulomatous

ArticleYear
The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.
    Clinical and experimental immunology, 2010, Volume: 160, Issue:3

    Topics: Adenoviridae; Colitis, Ulcerative; Colon; Complement C3; Crohn Disease; Dose-Response Relationship,

2010
IGF-I increases IGFBP-5 and collagen alpha1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells.
    American journal of physiology. Gastrointestinal and liver physiology, 2004, Volume: 286, Issue:5

    Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; Cells, Culture

2004